Competition and Markets Authority (CMA) rules that four pharma companies are guilty of anti-competitive behaviour

King Pharmaceuticals, Auden Mckenzie, Accord-UK and Alissa Healthcare have been found to have broken the law in relation to the anti-competitive supply of nortriptyline.

PharmaTimes